Giotrif 40 mg, film-coated tablets

( ARTG ) GIOTRIF is indicated as monotherapy for the treatment of adult patients with:, Locally advanced or metastatic non-squamous non-small cell carcinoma of the lung, either as first line therapy or after failure of cytotoxic chemotherapy. Tumours must have activating Epidermal Growth Factor Receptor (EGFR) mutations., Locally advanced or metastatic squamous non-small cell carcinoma of the lung progressing on or after platinum-based chemotherapy.